Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 161

Results For "patients"

3315 News Found

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips
Digitisation | April 18, 2023

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips

Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators


Ascentage presents results of studies underscoring exploratory efforts in potential
Clinical Trials | April 18, 2023

Ascentage presents results of studies underscoring exploratory efforts in potential

The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications


DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics
Biotech | April 18, 2023

DualityBio collaborates with BioNTech to accelerate development of differentiated antibody-drug conjugate therapeutics

WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.


Agilent showcases cancer portfolio Solutions at AACR 2023
Digitisation | April 18, 2023

Agilent showcases cancer portfolio Solutions at AACR 2023

From cancer research to diagnostic solutions


Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection
Drug Approval | April 17, 2023

Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection

Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output


Moderna and Merck announce an investigational individualized neoantigen therapy
Clinical Trials | April 17, 2023

Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Fibe partners with Pristyn Care to power affordable quality healthcare across India
Healthcare | April 15, 2023

Fibe partners with Pristyn Care to power affordable quality healthcare across India

Affordability is key to providing accessible healthcare for Bharat.


NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate
Drug Approval | April 15, 2023

NS Pharma announces FDA clearance to initiate phase II study for an Exon 44 skipping candidate

Study efficacy measures will include the expression of dystrophin protein and motor function.


Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology
Clinical Trials | April 15, 2023

Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology

Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging